Definium Therapeutics
The Associate Director, Statistical Programming provides statistical programming support for compounds at various stages of development, including clinical trials, regulatory filings, and commercialization. This role serves as the study lead programmer, overseeing vendor deliverables, performing data analysis, and collaborating with biostatisticians and data management teams to ensure high-quality outputs. The position requires expertise in CDISC standards, SAS programming, and regulatory submission requirements.
Headquarters
New York, New York, United States
Company Size
1-10 employees
Founded
2019
Definium Therapeutics (formerly MindMed) is a clinical-stage biopharmaceutical company harnessing the therapeutic potential of psychedelic medicine to develop treatments for psychiatric conditions including generalized anxiety disorder, major depressive disorder, and autism spectrum disorder. Its lead programs include DT120 ODT, a proprietary formulation of lysergide (LSD) D-tartrate, and DT402, the R-enantiomer of MDMA targeting core symptoms of autism spectrum disorder. The company is guided by precision science and evidence-based development to redefine mental healthcare.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Definium Therapeutics.
22% below the average for this role
Statistical Programmer
Bioclinica
Senior Manager, Statistical Programming
immunomeinc
Associate Director, Statistical Programming
Definium Therapeutics
Senior Principal Statistical Programmer
Iambic Therapeutics
Statistical Programming Associate Director
Sumitomo Pharma America, Inc
Statistical Programmer Contractor
ProKidney